Asian Currencies Consolidate Amid Rising Global Trade Tensions
0203 GMT — Asian currencies consolidate against the dollar in the morning session amid rising global trade tensions. 'Elevated trade uncertainty has now become a negative for business confidence, for investment, and for growth,' DBS Group Research's Chang Wei Liang says in a commentary. The outlook for U.S. economic exceptionalism could be fading, the FX & credit strategist says. The Dollar Index is consolidating around the mid-103s, getting little boost from escalating trade concerns, the strategist adds. USD/KRW edges 0.1% lower to 1,450.07; USD/SGD is little changed at 1.3326; USD/CNH is steady at 7.2396. (ronnie.harui@wsj.com)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Military & Simulation Training Market Global Outlook & Forecast 2025-2030, with Company Profiles for BAE Systems, CAE, Lockheed Martin, Rheinmetall, Saab and Thales
Key contracts include Raytheon's $191.1 million deal with the Missile Defense Agency and BAE Systems' $251 million contract with the U.S. Navy. Technological advancements in AR, VR, and AI are transforming training, reducing risks and costs. Increasing defense budgets and geopolitical tensions further drive demand in the sector. Military & Simulation Training Market Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "Military & Simulation Training Market - Global Outlook & Forecast 2025-2030" report has been added to Military & Simulation Training Market was valued at USD 13.39 Billion in 2024, and is projected to reach USD 21.08 Billion by 2030, rising at a CAGR of 7.86%. The global military simulation and training market is highly competitive, with several global players offering advanced virtual training solutions for defense forces. Key companies in the defense simulation and training market include Rheinmetall AG, CAE Inc., THALES, Lockheed Martin Corporation, Saab AB, and BAE Systems. These companies focus on technological advancements in simulation-based training, including artificial intelligence, virtual reality (VR), augmented reality (AR), and live, virtual, and constructive (LVC) training collaborations and partnerships play a crucial role in expanding market presence and enhancing service offerings. For instance, in January 2025, Rheinmetall AG and Bohemia Interactive Simulations (BISim) announced a strategic partnership to enhance defense simulation technologies. Furthermore, companies in the military simulation and training market are increasingly investing in research and development to improve the realism, effectiveness, and interoperability of their training solutions. The demand for high-fidelity simulators, AI-driven training programs, and cybersecurity simulation platforms is driving innovation in the leaders are adopting acquisition and joint venture strategies to strengthen their position in emerging markets. The growing emphasis on cost-effective and scalable training solutions, along with rising defense budgets and modernization programs, is intensifying competition. As military forces worldwide prioritize operational readiness and mission effectiveness, the military simulation and training market is expected to witness continued advancements in synthetic training environments and networked simulation systems. Recent Contracts in the Global Military Simulation and Training Market In December 2024, Raytheon secured a $191.1 million contract from the Missile Defense Agency to provide modeling and simulation services for U.S. Army and Navy missile defense systems, enhancing training and operational preparedness. The contract runs through October 2027, with work conducted in Huntsville, Alabama; Colorado Springs, Colorado; and Woburn, Massachusetts. In November 2024, Combat Robotics India, supported by DRDO, developed the "Astra" simulator for unmanned vehicles. This advanced simulator captures extensive operational data, enabling researchers to refine the design and functionality of unmanned vehicles to meet the evolving needs of the armed forces. In July 2024, Lockheed Martin was awarded a USD 4.6 million contract by DARPA to develop AI tools for dynamic, airborne missions. The project, part of DARPA's Artificial Intelligence Reinforcements (AIR) program, focuses on advanced modeling and simulation (M&S) approaches to support multi-ship, beyond visual range (BVR) missions, enhancing real-time decision-making in combat scenarios. In February 2025, BAE Systems secures a USD 251 million contract to support the U.S. Navy's AEGIS Combat System. Under this contract, BAE Systems will provide high-quality services in systems engineering, test and evaluation, logistics, system acquisitions, and cybersecurity. GLOBAL DEFENSE SIMULATION AND TRAINING MARKET TRENDS & OPPORTUNITIES Technological Advancements (In AR, VR & AI)Technological innovations in Augmented Reality (AR), Virtual Reality (VR), and Artificial Intelligence (AI) are revolutionizing the global military simulation and training market. These technologies are improving operational readiness, situational awareness, and combat readiness while decreasing training expenses and risks. The combination of these technologies has become vital to contemporary defense strategies, especially with militaries confronting ever-more complex and unpredictable combat instance, the adoption of these technologies is evident in the military forces of countries such as India and the UK. In the Indian military, the use of technology in the Indian Army's training process has transformed the conventional approach that has been followed for decades. Among the key changes is the application of VR and AR. These two technologies enable soldiers to be exposed to varied combat situations and landscapes, hence being better equipped for actual combat. For example, virtual simulations assist in parachute training, where soldiers go through the different phases of airborne operations in a simulated manner. Such training is risk-free and economical. Similarly, in the UK military, VR is utilized to enhance the effectiveness of training while minimizing the risks and costs associated with traditional military must also address the potential security risks and ethical concerns associated with AI applications. In 2023, a recent policy update from the Pentagon technology highlights the Department of Defense's commitment to ensuring that AI advancements benefit military objectives while maintaining ethical standards. The continued evolution of AI-driven military training and operational strategies is essential to ensuring that military forces remain effective and adaptable in a rapidly changing technological Defense BudgetsThere is growing instability driven by escalating geopolitical tensions, and countries worldwide are enhancing their military capabilities. For instance, according to SIPRI in 2024 World military expenditure rose for the ninth consecutive year to an all-time high of USD 2.44 trillion in 2023, an increase of 6.8% in real terms from 2022. The increasing defense budgets globally are directly tied to the growing emphasis on advanced military technologies and enhanced training methodologies, particularly in the realm of military and simulation training. As defense expenditures rise, nations are investing heavily in simulators, that replicate real-world combat environments and support the military simulation and training market prolonged war in Ukraine, as well as rising geopolitical tensions in Asia, Oceania, and the Middle East, are propelling global military spending, with countries allocating more of their budgets to defense and security. Furthermore, The USA and China are the top two biggest military spenders in the world in 2024, with the U.S. spending about USD 916 billion, while the Chinese estimated USD 296 billion, both accounting for around half of the global military spending in 2023-24. All these factors collectively are projected to support market RESTRAINTS Challenge of Skill RetentionIn the military world, retaining skills and keeping individuals engaged is essential for success. Just as companies implement strategies to retain skilled employees and reduce turnover, the military must create an environment that supports personnel in maintaining proficiency in their technical roles. This requires continuous training programs, opportunities for upskilling, and a culture that values ongoing education to ensure personnel remain capable and mission-ready. Balancing operational duties with structured training can help reduce skill degradation and maintain a motivated retention poses a particular challenge in the military simulation and training market, especially for roles that require lifesaving and technical expertise. Military personnel often face frequent rotations through assignments that may not align with their primary specializations. While these rotations promote adaptability, they also create gaps in critical skills. When these skills are not regularly practiced or reinforced, they tend to degrade over time, which can directly impact mission readiness and overall operational effectiveness. For instance, technical specialists, such as non-commissioned officers (NCOs) in fields like communications, maintenance, or medical services, are especially vulnerable to skill degradation when assigned to non-technical or administrative roles. GLOBAL MILITARY SIMULATION AND TRAINING MARKET GEOGRAPHICAL ANALYSISNorth America dominated the global military simulation and training market in 2024, accounting for more than 34% of total revenue, driven by significant defense spending, strong adoption of simulation-based training, and advancements in virtual and augmented reality (VR/AR) technologies. The US defense training & simulation market leads the North America region, with continuous investments in modernizing military training infrastructure and integrating AI in simulation systems. For instance, according to the Cascadia Aerospace and Defense Industry Report in 2024, the U.S. DoD has earmarked approximately USD 1.8 billion for artificial intelligence projects, reflecting a substantial 63.6% increase compared to the fiscal year 2023 allocation. The presence of major defense contractors and simulation technology providers further supports defense simulation and training market growth. Furthermore, Europe followed North America and holds a significant share of the military simulation and training market, supported by rising defense expenditures and strategic investments in military training programs. Countries such as the United Kingdom, Germany, Italy, and France are key players, focusing on enhancing operational readiness through advanced training solutions. The European market is also driven by joint military exercises, NATO-led training programs, and the adoption of synthetic training environments to reduce costs and improve training is witnessing rapid growth in the military simulation and training market due to increasing defense budgets in China, India, Japan, South Korea, and other regions. Governments in the region are prioritizing next-generation simulation technologies to improve combat readiness and reduce training costs. For instance, according to NT News in February 2025, the Open Plan Weapons Training Simulation System at Robertson Barracks in Darwin, Australia, exemplifies the region's investment in next-generation military simulation technologies. This facility, valued at USD 17 million, enhances combat readiness by providing realistic training environments while reducing training costs through simulation-based exercises. The growing adoption of unmanned systems and cybersecurity training further contributes to military simulation and training market East & Africa and Latin America are experiencing steady growth in the military simulation and training market, driven by military modernization programs and regional security challenges. In Latin America, countries like Brazil and Mexico are investing in simulation-based training to enhance defense preparedness. Meanwhile, in the MEA, Saudi Arabia and the UAE are leading investments in high-tech simulation systems, particularly in aerial and combat training, to strengthen their defense capabilities. The demand for cost-effective and scalable training solutions remains a key factor in these regions' market growth. DEFENSE MILITARY SIMULATION AND TRAINING MARKET SHARE & VENDOR LANDSCAPEKey Company Profiles BAE Systems CAE Inc. Lockheed Martin Corporation Rheinmetall AG Saab AB Thales Other Prominent Vendors Airbus Atos SE Barco Boeing Bohemia Interactive Simulations Collins Aerospace Cubic Corporation Elbit Systems Ltd. Exail Fidelity Technologies Corporation FlightSafety International General Dynamics Corporation Groupe Gorge HAVELSAN Inc. InVeris Training Solutions KONGSBERG Kratos Defense & Security Solutions, Inc. L3Harris Technologies, Inc. Leonardo S.p.A. MVRsimulation Inc Northrop Grumman PARKER HANNIFIN CORP Simthetiq ST Engineering Textron Inc. VSTEP B.V. Key Attributes: Report Attribute Details No. of Pages 293 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $13.39 Billion Forecasted Market Value (USD) by 2030 $21.08 Billion Compound Annual Growth Rate 7.8% Regions Covered Global SEGMENTATION INSIGHTSSegmentation by Application Combat Training MRO Leadership Others Segmentation by Platform Aerial Navel Land Segmentation by Region Military Simulation and Training Market in APAC China India South Korea Indonesia Taiwan Japan Australia North America The U.S. Canada Europe France Germany Italy The U.K. Poland Spain Netherlands Middle East & Africa Egypt Turkey Saudi Arabia UAE Latin America Brazil Colombia Argentina For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Military & Simulation Training Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
an hour ago
- Yahoo
Over the Counter (OTC) Drugs Market Report 2025: Opportunities, Growth Drivers, Industry Trend Analysis, and Forecasts to 2034
Driven by self-medication trends, health-conscious consumers, and innovative formulations, the OTC drugs market thrives on the widespread availability of non-prescription drugs. Key segments include cold remedies and tablets, heavily favored for convenience. The U.S. market alone is expected to expand at a 4.8% CAGR, fueled by strong R&D and self-care trends. Over the Counter (OTC) Drugs Market Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "Over the Counter (OTC) Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to Over the Counter (OTC) Drugs Market was valued at USD 180 Billion in 2024, and is projected to reach USD 302.3 Billion by 2034, rising at a CAGR of 5.40%, driven largely by a rising consumer preference for self-medication and increasing demand for accessible healthcare solutions. As consumers become more health-conscious and proactive in managing minor ailments, OTC drugs are quickly emerging as a go-to solution for quick relief and cost-effective treatment options. The widespread availability of OTC products in pharmacies, supermarkets, online platforms, and convenience stores is making it easier for consumers to access essential medications without a prescription. In addition, ongoing advancements in drug formulations, such as fast-dissolving tablets and flavored syrups, are enhancing user convenience and compliance, fueling market growth even further. Regulatory bodies across the globe are also playing a crucial role by ensuring stringent quality checks and guidelines, which boost consumer confidence in using OTC medications for everyday health concerns. As healthcare costs continue to rise, many individuals are opting for OTC options to manage common conditions like pain, colds, digestive issues, and skin irritations without the need for physician visits, thereby contributing to overall market expansion. Furthermore, an aging population seeking easy and affordable solutions for recurring issues like joint pain, digestive discomfort, and sleep disorders is supporting long-term demand for OTC products. The growing trend toward preventive healthcare and wellness supplements is also influencing consumer purchasing behavior, with many people adopting vitamins, minerals, and herbal supplements as part of their daily routines to maintain health and drugs, which do not require a doctor's prescription, are carefully regulated by health authorities to ensure their safety, efficacy, and quality. These medications are available in diverse forms, such as tablets, ointments, sprays, and solutions, offering users convenient options for managing common health issues at home. The market is segmented into various categories, including cold and cough remedies, vitamins and supplements, digestive aids, skin treatments, pain relievers, sleeping aids, and others. Among these, cold and cough remedies generated USD 45.2 billion in 2024, as the rising incidence of respiratory illnesses like colds and flu, particularly during seasonal transitions, drives demand for quick-relief products such as decongestants and cough looking at product formulation, tablets dominated the OTC market with USD 85.9 billion in 2024, as they remain the preferred choice due to precise dosing, convenience, and ease of use for treating conditions such as pain, respiratory issues, and other acute ailments. The consistent launch of new tablet-based OTC products continues to boost their market regional analysis, the U.S. OTC Drugs Market accounted for USD 42.4 billion in 2024 and is anticipated to grow at a 4.8% CAGR through 2034. The country's robust pharmaceutical landscape, significant R&D investments, and rising consumer inclination toward self-care are propelling market growth alongside growing awareness around early treatment and preventive healthcare Market Analysis and Forecast Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape Competitive landscape with Porter's Five Forces and PESTEL analysis Market size, segmentation, and regional forecasts In-depth company profiles, business strategies, financial insights, and SWOT analysis The companies profiled in this Over the Counter (OTC) Drugs market report include: Abbott Alkem Laboratories Aytu Biopharma (Aytu Consumer Health) Bayer AG Cipla Dr. Reddy's Laboratories GlaxoSmithKline Plc Glenmark Pharmaceuticals Haleon Johnson & Johnson Services Perrigo Company Pfizer Piramal Enterprises Reckitt Benckiser Group Sanofi Sun Pharmaceuticals Teva Pharmaceutical Industries The Blackstone Group (Alinamin Pharmaceutical) Viatris Key Attributes: Report Attribute Details No. of Pages 130 Forecast Period 2024 - 2034 Estimated Market Value (USD) in 2024 $180 Billion Forecasted Market Value (USD) by 2034 $302.3 Billion Compound Annual Growth Rate 5.4% Regions Covered Global Key Topics Covered: Chapter 1 Methodology and ScopeChapter 2 Executive Summary2.1 Industry 360 degree synopsisChapter 3 Industry Insights3.1 Industry ecosystem analysis3.2 Industry impact forces3.2.1 Growth drivers3.2.1.1 Growing consumer awareness for self-medication and disease management3.2.1.2 High cost of prescription drugs leading to shift towards OTC drugs3.2.1.3 Favorable regulatory support for OTC drug approvals3.2.1.4 Expanding product accessibility3.2.2 Industry pitfalls and challenges3.2.2.1 Concern towards misuse or drug abuse3.2.2.2 Potential side effects and interactions due to medication3.3 Growth potential analysis3.4 Regulatory landscape3.5 Prescription to nonprescription switch list3.6 Future market trends3.7 Porter's analysis3.8 PESTEL analysisChapter 4 Competitive Landscape, 20244.1 Introduction4.2 Company matrix analysis4.3 Company market share analysis4.4 Competitive analysis of major market players4.5 Competitive positioning matrix4.6 Strategy dashboardChapter 5 Market Estimates and Forecast, by Drug Category, 2021-2034 ($ Mn)5.1 Key trends5.2 Cold and cough remedies5.3 Vitamins and supplements5.4 Digestive and intestinal remedies5.5 Skin treatment5.6 Analgesics5.7 Sleeping aids5.8 Other drug categoriesChapter 6 Market Estimates and Forecast, by Formulation Type, 2021-2034 ($ Mn)6.1 Key trends6.2 Tablets6.3 Liquids6.4 Ointments6.5 SpraysChapter 7 Market Estimates and Forecast, by Distribution Channel, 2021-2034 ($ Mn)7.1 Key trends7.2 Online channels7.3 Offline channels7.3.1 Hospital pharmacies7.3.2 Retail pharmacies7.3.3 Other offline channelsChapter 8 Market Estimates and Forecast, by Region, 2021-2034 ($ Mn)8.1 Key trends8.2 North America8.2.1 U.S.8.2.2 Canada8.3 Europe8.3.1 Germany8.3.2 UK8.3.3 France8.3.4 Spain8.3.5 Italy8.3.6 Netherlands8.4 Asia Pacific8.4.1 China8.4.2 India8.4.3 Japan8.4.4 Australia8.4.5 South Korea8.5 Latin America8.5.1 Brazil8.5.2 Mexico8.5.3 Argentina8.6 Middle East and Africa8.6.1 South Africa8.6.2 Saudi Arabia8.6.3 UAEChapter 9 Company Profiles9.1 Abbott9.2 Alkem Laboratories9.3 Aytu Biopharma (Aytu Consumer Health)9.4 Bayer AG9.5 Cipla9.6 Dr. Reddy's Laboratories9.7 GlaxoSmithKline Plc9.8 Glenmark Pharmaceuticals9.9 Haleon9.10 Johnson & Johnson Services9.11 Perrigo Company9.12 Pfizer9.13 Piramal Enterprises9.14 Reckitt Benckiser Group9.15 Sanofi9.16 Sun Pharmaceuticals9.17 Teva Pharmaceutical Industries9.18 The Blackstone Group (Alinamin Pharmaceutical)9.19 ViatrisCompanies Featured The companies profiled in this Over the Counter (OTC) Drugs market report include: Abbott Alkem Laboratories Aytu Biopharma (Aytu Consumer Health) Bayer AG Cipla Dr. Reddy's Laboratories GlaxoSmithKline Plc Glenmark Pharmaceuticals Haleon Johnson & Johnson Services Perrigo Company Pfizer Piramal Enterprises Reckitt Benckiser Group Sanofi Sun Pharmaceuticals Teva Pharmaceutical Industries The Blackstone Group (Alinamin Pharmaceutical) Viatris For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Over the Counter (OTC) Drugs Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Oncology Market Global Report 2025: Industry Trends, Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape
Innovations in immunotherapies and personalized medicine, along with increased healthcare investments, are reshaping cancer care. The U.S. market stands out with a projected USD 377.1 billion valuation by 2034, thanks to robust R&D and government support, enhancing treatment accessibility and precision oncology adoption. Oncology Market Dublin, June 04, 2025 (GLOBE NEWSWIRE) -- The "Oncology Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to Oncology Market was valued at USD 320.3 billion in 2024, and is projected to reach USD 866.1 billion by 2034, rising at a CAGR of 10.8%. The rising incidence of cancer worldwide remains the key driver of market expansion, prompting increased demand for advanced treatments and diagnostics. As cancer cases surge across all age groups, healthcare systems are intensifying efforts to improve patient outcomes through novel therapies, precision medicine, and technological advancements in diagnostics. The oncology sector continues to witness significant investment from pharmaceutical and biotechnology firms, leading to groundbreaking innovations in immunotherapies, targeted therapies, and early detection methods. The growing focus on personalized medicine, driven by genomics and biomarker research, is transforming the landscape of cancer treatment. Government initiatives, rising healthcare expenditures, and increased awareness campaigns further contribute to market growth, emphasizing the urgent need for better accessibility to cutting-edge cancer therapies and diagnostics. The oncology market is categorized into two primary segments: cancer diagnostics and cancer treatment. The cancer treatment segment, valued at USD 174.8 billion in 2024, is anticipated to grow at a CAGR of 11.3% between 2025 and 2034. The expansion of this segment is attributed to an increasing number of cancer diagnoses and regulatory approvals for novel treatments. Recent breakthroughs, including CAR-T cell therapies and next-generation immunotherapies, are reshaping cancer care, offering patients enhanced survival rates and improved quality of life. As pharmaceutical companies accelerate research and development efforts, the pipeline for innovative oncology drugs continues to expand, providing new hope for patients battling various forms of encompasses several cancer types, including lung, prostate, breast, and colorectal cancers. In 2024, the breast cancer segment accounted for USD 63.2 billion, securing a 20% market share. The rising prevalence of breast cancer, coupled with advancements in diagnostic imaging, liquid biopsies, and targeted therapies, fuels the segment's rapid growth. Increased awareness campaigns and enhanced screening programs are enabling early detection, significantly improving treatment success rates. The growing adoption of artificial intelligence in diagnostics and precision medicine in breast cancer treatment is also driving market expansion, paving the way for more effective, patient-centric therapeutic solutions.U.S. Oncology Market is poised to reach USD 377.1 billion by 2034, positioning the country as a global leader in cancer research and treatment. The increasing cancer burden, combined with strong government support and robust investment from pharmaceutical and biotechnology companies, is accelerating innovation in the oncology sector. With a growing number of hospitals, research institutions, and healthcare providers focusing on developing next-generation diagnostic tools and therapies, the U.S. continues to spearhead advancements in cancer care. The rising adoption of precision oncology, expansion of clinical trials, and continuous improvements in treatment accessibility further strengthen the market's trajectory, ensuring a steady demand for breakthrough cancer treatments and cutting-edge diagnostic Market Analysis and Forecast Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape Competitive landscape with Porter's Five Forces and PESTEL analysis Market size, segmentation, and regional forecasts In-depth company profiles, business strategies, financial insights, and SWOT analysis The companies featured in this Oncology market report include: AbbVie Amgen AstraZeneca Bristol-Myers Squibb Company Eli Lilly and Company GE HealthCare Technologies Gilead Sciences GlaxoSmithKline Johnson & Johnson Merck & Co Novartis Pfizer F. Hoffmann-La Roche Sanofi Takeda Pharmaceutical Company Limited Key Attributes: Report Attribute Details No. of Pages 135 Forecast Period 2024 - 2034 Estimated Market Value (USD) in 2024 $320.3 Billion Forecasted Market Value (USD) by 2034 $866.1 Billion Compound Annual Growth Rate 10.8% Regions Covered Global Key Topics Covered: Chapter 1 Methodology and ScopeChapter 2 Executive Summary2.1 Industry 360 synopsisChapter 3 Industry Insights3.1 Industry ecosystem analysis3.2 Industry impact forces3.2.1 Growth drivers3.2.1.1 Rising incidence of cancer globally3.2.1.2 Several initiatives undertaken by government and other organizations to spread disease awareness3.2.1.3 Growing number of diagnostic laboratories in developing countries3.2.1.4 Technological advancements in developed countries3.2.2 Industry pitfalls and challenges3.2.2.1 High capital investment coupled with high cost associated with diagnostic imaging system3.2.2.2 High risk of side effects associated with cancer treatment and risks associated with CT scanners3.2.2.3 Dearth of well-skilled and trained oncologists and radiologists3.3 Growth potential analysis3.4 Regulatory landscape3.5 Technological landscape3.6 Future market trends3.7 Gap analysis3.8 Porter's analysis3.9 PESTEL analysisChapter 4 Competitive Landscape, 20244.1 Introduction4.2 Company market share analysis4.3 Company matrix analysis4.4 Competitive analysis of major market players4.5 Competitive positioning matrix4.6 Strategy dashboardChapter 5 Market Estimates and Forecast, by Cancer Diagnostics and Treatment, 2021-2034 ($ Mn)5.1 Key trends5.2 Cancer diagnostics5.2.1 Tumor biomarkers test5.2.2 Imaging5.2.3 Biopsy5.2.4 Liquid biopsy5.2.5 Immunohistochemistry5.2.6 In situ hybridization5.3 Cancer treatment5.3.1 Chemotherapy5.3.2 Targeted therapy5.3.3 Immunotherapy5.3.4 Hormonal therapy5.3.5 Other cancer treatmentsChapter 6 Market Estimates and Forecast, by Cancer Type, 2021-2034 ($ Mn)6.1 Key trends6.2 Lung cancer6.3 Prostate cancer6.4 Colon and rectal cancer6.5 Gastric cancer6.6 Esophageal cancer6.7 Liver cancer6.8 Breast cancer6.9 Other cancer typesChapter 7 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)7.1 Key trends7.2 Hospitals7.3 Diagnostic laboratories7.4 Diagnostic imaging centers7.5 Academia7.6 Specialty clinics7.7 Other end useChapter 8 Market Estimates and Forecast, by Region, 2021-2034 ($ Mn)Chapter 9 Company Profiles9.1 AbbVie9.2 Amgen9.3 AstraZeneca9.4 Bristol-Myers Squibb Company9.5 Eli Lilly and Company9.6 GE HealthCare Technologies9.7 Gilead Sciences9.8 GlaxoSmithKline9.9 Johnson & Johnson9.10 Merck & Co9.11 Novartis9.12 Pfizer9.13 F. Hoffmann-La Roche9.14 Sanofi9.15 Takeda Pharmaceutical Company LimitedFor more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Oncology Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
